Skip to main content
Market intelligence
MRKHealthcare

Merck & Co Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 13, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 13, 2026Chirfi GuindoEVP, Access, Policy & CommsSale10,000$135.00$1,350,000
Aug 12, 2026Jennifer ZacharyEVP, General CounselSale80,315$133.46$10,718,495
Aug 12, 2026Richard R. DeLucaEVP&Pres, Merck Animal HeallthSale45,320$131.12$5,942,367